On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.

Kennedy Jr. has downplayed the effectiveness of the long-used vaccine and instead promoted the development of new treatments ...

Sail Biomedicines is shrinking its crew for the second time this year. | Sail Biomedicines is shrinking its crew for the ...

Reeling from the deaths of two patients who took Duchenne muscular dystrophy gene therapy Elevidys, Sarepta is launching a ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the ...

The U.K. is establishing a new biosecurity center designed to improve research into potentially pandemic-causing pathogens ...

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent ...

The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. | Sino Biopharm said ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...